ARTICLES |
Parenteral Glutamine Supplementation Does Not Reduce the Risk of Mortality or Late-Onset Sepsis in Extremely Low Birth Weight Infants












* Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana
Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
|| National Institute of Child Health and Human Development, Bethesda, Maryland
¶ Research Triangle Institute, Research Triangle Park, North Carolina
# Department of Pediatrics, Brown University, Providence, Rhode Island
** Department of Pediatrics, University of Miami, Miami, Florida

Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, New Mexico

Center for Clinical Research and Evidence Based Medicine, University of Texas Health Science Center at Houston Medical School, Houston, Texas
|||| Department of Pediatrics, University of Alabama, Birmingham, Alabama
¶¶ Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas
## Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio
*** Division of Neonatology, Stanford University Medical Center, Palo Alto, California


Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio


The Newborn Center, University of Tennessee, Memphis, Tennessee
|||||| Division of Neonatology and Perinatal Medicine, Wayne State University, Detroit, Michigan
¶¶¶ University of California at San Diego Medical Center, University of California, San Diego, California
ABSTRACT
Background. Glutamine is one of the most abundant amino acids in both plasma and human milk, yet it is not included in standard intravenous amino acid solutions. Previous studies have suggested that parenteral nutrition (PN) supplemented with glutamine may reduce sepsis and mortality in critically ill adults. Whether glutamine supplementation would provide a similar benefit to extremely low birth weight (ELBW) infants is not known.
Methods. We performed a multicenter, randomized, double-masked, clinical trial to assess the safety and efficacy of early PN supplemented with glutamine in decreasing the risk of death or late-onset sepsis in ELBW infants. Infants 401 to 1000 g were randomized within 72 hours of birth to receive either TrophAmine (control) or an isonitrogenous study amino acid solution with 20% glutamine whenever they received PN up to 120 days of age, death, or discharge from the hospital. The primary outcome was death or late-onset sepsis.
Results. Of the 721 infants who were assigned to glutamine supplementation, 370 (51%) died or developed late-onset sepsis, as compared with 343 of the 712 infants (48%) assigned to control (relative risk: 1.07; 95% confidence interval: 0.971.17). Glutamine had no effect on tolerance of enteral feeds, necrotizing enterocolitis, or growth. No significant adverse events were observed with glutamine supplementation.
Conclusions. Parenteral glutamine supplementation as studied did not decrease mortality or the incidence of late-onset sepsis in ELBW infants. Consequently, although no harm was demonstrated, routine use of parenteral glutamine supplementation cannot be recommended in this population.
Key Words: glutamine parenteral nutrition extremely low birth weight infants randomized clinical trial
Abbreviations: PN, parenteral nutrition ELBW, extremely low birth weight RR, relative risk CI, confidence interval
Received for publication May 15, 2003; Accepted Jul 23, 2003.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. Neu Use of Nutrition to Prevent Stress-induced Immunosuppression in the Pediatric Intensive Care Unit: A Clinical Trials Minefield JPEN J Parenter Enteral Nutr, July 1, 2009; 33(4): 440 - 441. [Full Text] [PDF] |
||||
![]() |
M. Peralta-Carcelen, M. Moses, I. Adams-Chapman, M. Gantz, B. R. Vohr, and for the NICHD Neonatal Research Network Stability of Neuromotor Outcomes at 18 and 30 Months of Age After Extremely Low Birth Weight Status Pediatrics, May 1, 2009; 123(5): e887 - e895. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Skillman and P. E. Wischmeyer Nutrition Therapy in Critically Ill Infants and Children JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 520 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Raghuveer and J. M. Belmont Human Milk Intake and Retinopathy of Prematurity in Extremely Low Birth Weight Infants Pediatrics, September 1, 2008; 122(3): 686 - 687. [Full Text] [PDF] |
||||
![]() |
C. F. Estivariz, D. P. Griffith, M. Luo, E. E. Szeszycki, N. Bazargan, N. Dave, N. M. Daignault, G. F. Bergman, T. McNally, C. H. Battey, et al. Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections in Critically Ill Surgical Patients JPEN J Parenter Enteral Nutr, July 1, 2008; 32(4): 389 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van den Berg, A. van Zwol, H. A. Moll, W. P. F. Fetter, and R. M. van Elburg Glutamine-Enriched Enteral Nutrition in Very Low-Birth-Weight Infants: Effect on the Incidence of Allergic and Infectious Diseases in the First Year of Life Arch Pediatr Adolesc Med, November 1, 2007; 161(11): 1095 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Heller, M. O'Shea, Q. Yao, J. Langer, R. A. Ehrenkranz, D. L. Phelps, W. K. Poole, B. Stoll, S. Duara, W. Oh, et al. Human Milk Intake and Retinopathy of Prematurity in Extremely Low Birth Weight Infants Pediatrics, July 1, 2007; 120(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Brunton, A. K. Shoveller, P. B. Pencharz, and R. O. Ball The Indicator Amino Acid Oxidation Method Identified Limiting Amino Acids in Two Parenteral Nutrition Solutions in Neonatal Piglets J. Nutr., May 1, 2007; 137(5): 1253 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C Denne Regulation of proteolysis and optimal protein accretion in extremely premature newborns Am. J. Clinical Nutrition, February 1, 2007; 85(2): 621S - 624S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van den Berg, W. P. F. Fetter, E. A. M. Westerbeek, I. M. van der Vegt, H. R. A. van der Molen, and R. M. van Elburg The Effect of Glutamine-Enriched Enteral Nutrition on Intestinal Permeability in Very-Low-Birth-Weight Infants: A Randomized Controlled Trial JPEN J Parenter Enteral Nutr, September 1, 2006; 30(5): 408 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neu, A. Afzal, H. Pan, E. Gallego, N. Li, S. L. Calzi, S. Caballero, P. E. Spoerri, L. C. Shaw, and M. B. Grant The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3151 - 3155. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Vohr, B. B. Poindexter, A. M. Dusick, L. T. McKinley, L. L. Wright, J. C. Langer, W. K. Poole, and for the NICHD Neonatal Research Network Beneficial Effects of Breast Milk in the Neonatal Intensive Care Unit on the Developmental Outcome of Extremely Low Birth Weight Infants at 18 Months of Age Pediatrics, July 1, 2006; 118(1): e115 - e123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kadrofske, P. S. Parimi, L. L. Gruca, and S. C. Kalhan Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E622 - E630. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jesse and J. Neu Necrotizing Enterocolitis: Relationship to Innate Immunity, Clinical Features, and Strategies for Prevention NeoReviews, March 1, 2006; 7(3): e143 - e150. [Full Text] [PDF] |
||||
![]() |
J W L Puntis Nutritional support in the premature newborn. Postgrad. Med. J., March 1, 2006; 82(965): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van den Berg, R. M van Elburg, E. A. Westerbeek, J. W. Twisk, and W. P. Fetter Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1397 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF] |
||||














